News – Page 360 – Endpoints News

Bipartisan Senate legislation to reform PBMs, improve FDA processes kicks off with a markup next week

3 years ago

FDA hands Arbutus clinical hold on IND for hepatitis PD-L1

3 years ago

‘Dawn of oral therapy’: Morphic touts UC data in march toward Takeda’s Entyvio

3 years ago

Novartis pays German biotech $40M for radioligand therapy, diagnostic hitting 'first-in-class' target

3 years ago

Updated: Novartis trims pipeline by 10% as Vas Narasimhan places premium on 'high-value medicines'

3 years ago

Updated: Biogen chops certain stroke and RNA therapy programs as it continues R&D revamp

3 years ago

Florida-based biotech with approved cardiovascular therapy moves to go public via SPAC

3 years ago

$200M SPAC funded by billionaire Michael Dell will unwind after failing to find a partner

3 years ago

From CRL to buyout in five months: Assertio to acquire Spectrum in $248M stock deal

3 years ago

Vertex buys in on Stablix's protein stabilization approach in research and licensing deal

3 years ago

Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD

3 years ago

Ferring builds out partnerships, taps social media to amplify fertility conversations

3 years ago

Samsung Biologics to expand manufacturing in South Korea; WuXi AppTec expects up to 7% revenue growth this year

3 years ago

Genmab to appeal Darzalex arbitration against J&J

3 years ago

BioMarin makes $41M+ expansion to Irish facility

3 years ago

European pharma overhaul draft is coming Wednesday: Here's what's expected

3 years ago

Boehringer Ingelheim kicks off €350M R&D center in Germany

3 years ago

Applied Therapeutics says rare disease drug fails PhIII trial, still plans to seek approval

3 years ago

4D Molecular Therapeutics acquires eye disease asset from Fortress Biotech subsidiary

3 years ago

Aurinia shareholder calls for sale talks, nixes support for CEO and chair

3 years ago

Lilly will test its weight loss drug directly against Novo Nordisk's Wegovy

3 years ago

On Vertex and CRISPR Therapeutics’ heels, bluebird submits sickle cell gene therapy to FDA

3 years ago

FDA puts second Foghorn study on partial hold after serious heart event

3 years ago

FDA lifts nearly two-year hold on MaaT Pharma's microbiome therapy, opens door to PhIII

3 years ago

First page Previous page 357 358 359360361 362 363 Next page Last page